TB/HIV co-infection
Showing 1 - 25 of >10,000
MDR-TB, HIV Trial in South Africa (NCM-Plus)
Active, not recruiting
- MDR-TB
- HIV
- NCM-Plus
-
Westville, Durban, South Africa
- +14 more
Nov 16, 2021
Diagnosis of Tuberculosis Infection in HIV Co-infected Children
Completed
- Latent Tuberculosis Infection
- +2 more
-
Tygerberg, Western Cape, South AfricaDespond TuTu TB Centre, Stellenbosch University
Jan 3, 2022
Tuberculosis, HIV Coinfection, Tuberculosis Infection Trial (patient-centered TB preventive therapy, TB preventive therapy
Not yet recruiting
- Tuberculosis
- +2 more
- patient-centered TB preventive therapy
- TB preventive therapy adherence support
- (no location specified)
Apr 21, 2022
Interferon-Gamma Release Assays in Tuberculosis - HIV
Completed
- Tuberculosis
- HIV
- Interferon-Gamma Release Assay
- RT-23
-
Cape Town, Western Cape, South AfricaUniversity of Stellenbosch
Jan 3, 2022
Liver Cirrhosis Trial in Bunkyo-Ku (Foscenvivint)
Not yet recruiting
- Liver Cirrhosis
-
Bunkyo-Ku, Tokyo, JapanTokyo Metropolitan Komagome Hospital
Nov 29, 2023
Tuberculosis, Pulmonary Tuberculosis, HIV Coinfection Trial in Johannesburg (Isoniazid, Rifampicin, Ethambutol)
Recruiting
- Tuberculosis
- +2 more
- Isoniazid
- +4 more
-
Johannesburg, Gauteng, South AfricaTembisa Clinical Research Centre-The Aurum Institute
Jun 8, 2022
HIV/AIDS, Tuberculosis, Pulmonary Trial in Durban (Biktarvy®, TLD- fixed-drug combination single tablet)
Recruiting
- HIV/AIDS
- Tuberculosis, Pulmonary
- Biktarvy®
- TLD- fixed-drug combination single tablet
-
Durban, KwaZulu-Natal, South AfricaCAPRISA Springfield Clinical Research Site
Mar 14, 2022
HIV/TB Coinfection Trial in Thailand (DTG 50 mg OD with food, DTG 50 mg BID)
Recruiting
- HIV/TB Coinfection
- DTG 50 mg OD with food
- DTG 50 mg BID
-
Chiang Rai, Chiangrai, Thailand
- +9 more
Mar 22, 2022
or Rifampicin, Isoniazid, Pyrazinamide and Ethambutol in TB-HIV
Not yet recruiting
- Tuberculosis
- Pulmonary
-
Kampala, Uganda
- +3 more
Jul 12, 2021
Tuberculosis Infection, HIV Trial in Zomba (CAD4TB, FujiLAM)
Completed
- Tuberculosis Infection
- HIV Infections
- CAD4TB
- FujiLAM
-
Zomba, MalawiZomba Central Hospital
Jan 23, 2023
Community TB Services Pre and Post the CHIP-TB Trial
Recruiting
- Tuberculosis Infection
- Tuberculosis Prevention
-
Addis Ababa, Ethiopia
- +1 more
Jun 8, 2022
Pediatric HIV Infection, Tuberculosis Infection Trial (rifampicin)
Not yet recruiting
- Pediatric HIV Infection
- Tuberculosis Infection
- (no location specified)
Sep 26, 2021
Tuberculosis, HIV-1-infection, Immuno-Deficiency Trial in Worldwide (Intensified TB treatment (initial phase), WHO standard TB
Recruiting
- Tuberculosis
- +2 more
- Intensified TB treatment (initial phase)
- WHO standard TB treatment (initial phase)
-
Phnom Penh, Cambodia
- +5 more
May 3, 2022
Liver Cirrhosis Trial in Bunkyo-Ku (OP-724)
Active, not recruiting
- Liver Cirrhosis
-
Bunkyo-Ku, Tokyo, JapanTokyo Metropolitan Komagome Hospital
Jul 7, 2022
Pharmaceutical Care, HIV/AIDS, Tuberculosis Trial in Jakarta, Bekasi, Jakarta Pusat (Pharmaceutical Care)
Completed
- Pharmaceutical Care
- +2 more
- Pharmaceutical Care
-
Jakarta, Jakarta Timur, Indonesia
- +2 more
Mar 26, 2020
Human Immunodeficiency Virus (HIV) Infection Trial in Maseru, Blantyre (ART first- Therapeutic use trial, TB results first-
Recruiting
- Human Immunodeficiency Virus (HIV) Infection
- ART first- Therapeutic use trial
- TB results first- Therapeutic use trial
-
Maseru, Lesotho
- +1 more
Aug 10, 2022
HIV-infected Participants With Latent TB Infection in High TB Burden Country Trial in Thailand (Isoniazid/Rifapentine daily (4
Recruiting
- HIV-infected Participants With Latent TB Infection in High TB Burden Country
- Isoniazid/Rifapentine daily (4 weeks) plus pyridoxine (vitamin B6)
- Isoniazid/Rifapentine 12-weekly plus pyridoxine (vitamin B6)
-
Bangkok, Thailand
- +15 more
Mar 22, 2022
HCV Care and Treatment for HIV-HCV Co-infected Decentralised
Not yet recruiting
- HIV Infection
- Hepatitis C Infection
- Blood samples
-
Vinh, Nghe An, Vietnam
- +1 more
Aug 16, 2022
Outcomes in Tuberculous Patients in Sohag Governorate
Recruiting
- Tuberculosis
- sputum analysis
- lymph node biobsy
-
Sohag, EgyptSohag university Hospital
Nov 15, 2023
Infection, Human Immunodeficiency Virus, HIV Trial in Worldwide (DTG 50 mg, EFV 600 mg)
Completed
- Infection, Human Immunodeficiency Virus
- HIV Infections
- DTG 50 mg
- EFV 600 mg
-
Ciudad de Buenos Aires, Buenos Aires, Argentina
- +27 more
Dec 18, 2020
HIV, Tuberculosis Trial in Worldwide (Efavirenz (EFV), Rifampin-containing anti-TB therapy)
Completed
- HIV Infections
- Tuberculosis
- Efavirenz (EFV)
- Rifampin-containing anti-TB therapy
-
Pune, Maharashtra, India
- +6 more
Oct 28, 2021
/or Prognostic Markers of IRIS in TB-HIV Co-infected Patients
Unknown status
- HIV Infection
- Tuberculosis Infection
- Detection of molecular Biomarkers
-
Phnom Penh, CambodiaInstitut Pasteur du Cambodge
Jan 6, 2020
Tuberculosis, HIV I Infection, Sepsis Trial in Sanya Juu, Mbarara (Immediate anti-TB therapy, Sepsis-specific dose anti-TB
Recruiting
- Tuberculosis
- +2 more
- Immediate anti-TB therapy
- Sepsis-specific dose anti-TB therapy
-
Sanya Juu, Tanzania
- +1 more
Dec 10, 2021
Emergence of HIV Drug Resistance Following Initiation of TLD
Recruiting
- HIV-1-infection
-
Port-au-Prince, Bicentaire, Haiti
- +13 more
Feb 22, 2022